Explain this page
Arphra AIPlain-English read on The Estée Lauder Companies Inc.’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Quality composite
CMixed
A snapshot of the latest fiscal year’s margins, returns on capital, balance-sheet strength and efficiency, computed from the income statement, balance sheet and cash-flow rows. Source income / balance / cash_flow.
Profitability
Gross margin73.9%
Operating margin6.7%
Net margin-7.9%
ROE-29.3%
ROA-5.7%
ROIC10.1%
Liquidity & leverage
Current ratio1.30×
Quick ratio0.92×
Debt / equity2.44×
Net debt / EBITDA33.77×
Interest coverage2×
Efficiency & per-share
Asset turnover0.72×
Inventory days203
Days sales out.39
FCF / share$1.86
Book value / share$10.73
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Headline | |||||||||
| Market cap | — | — | — | $37.83B | $29.1B | — | — | — | — |
| Enterprise value | — | — | — | $44.26B | $35.61B | — | — | — | — |
| Multiples | |||||||||
| P / E | — | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | 2.84 | 2.49 | — | — | — | — |
| EV / FCF | — | — | — | 30.72 | 53.16 | — | — | — | — |
| Yields | |||||||||
| Earnings yield | — | — | — | +1.03% | -3.89% | — | — | — | — |
| Free cash flow yield | — | — | — | +3.81% | +2.30% | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||
| Gross margin | +76.36% | +75.73% | +71.31% | +71.66% | +73.89% | +72.54% | +70.95% | +72.87% | +72.55% |
| Operating margin | +16.15% | +17.87% | +9.48% | +6.21% | +6.70% | +7.60% | +7.47% | +7.57% | +7.25% |
| EBITDA margin | +25.62% | +22.16% | +15.06% | +12.65% | +1.35% | +9.91% | +9.77% | +9.62% | +9.52% |
| EBIT margin | +21.61% | +18.06% | +10.38% | +7.37% | -4.45% | +4.32% | +4.41% | +4.50% | +4.45% |
| Pre-tax margin | +20.54% | +17.12% | +8.78% | +4.95% | -7.28% | +2.12% | +2.21% | +2.10% | +2.21% |
| Net margin | +17.70% | +13.47% | +6.32% | +2.50% | -7.93% | +0.30% | +0.31% | +0.30% | +0.30% |
| Cost structure | |||||||||
| Cost of revenue / sales | +23.64% | +24.27% | +28.69% | +28.34% | +26.11% | +28.40% | +27.14% | +27.92% | +27.36% |
| R&D intensity | +1.50% | 0.00% | 0.00% | 0.00% | +2.21% | +0.72% | +0.75% | +0.72% | +0.72% |
| SG&A intensity | +57.79% | +55.75% | +60.18% | +61.64% | +64.98% | +63.25% | +62.12% | +61.99% | +61.36% |
| Effective tax rate | +13.69% | +20.69% | +27.70% | +47.02% | — | +38.86% | +36.36% | +38.15% | +37.32% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Returns | |||||||||
| Return on equity (ROE) | +41.31% | +37.16% | +15.68% | +7.34% | -29.31% | +0.91% | +0.90% | +0.89% | +0.88% |
| Return on assets (ROA) | +13.06% | +11.43% | +4.30% | +1.80% | -5.70% | +0.22% | +0.22% | +0.20% | +0.21% |
| Return on capital (ROC) | +17.40% | +22.52% | +9.10% | +6.41% | +7.20% | +7.91% | +7.59% | +7.80% | +7.39% |
| Return on invested capital (ROIC) | +19.07% | +16.98% | +6.07% | +2.58% | +5.40% | +0.31% | +0.31% | +0.30% | +0.30% |
| Asset turnover | +73.80% | +84.83% | +67.95% | +72.00% | +71.83% | +72.28% | +71.78% | +68.52% | +69.74% |
| DuPont · ROE decomposition | |||||||||
| Net margin | +17.70% | +13.47% | +6.32% | +2.50% | -7.93% | +0.30% | +0.31% | +0.30% | +0.30% |
| Asset turnover (× revenue / assets) | +73.80% | +84.83% | +67.95% | +72.00% | +71.83% | +72.28% | +71.78% | +68.52% | +69.74% |
| Equity multiplier (× assets / equity) | +316.22% | +325.09% | +364.89% | +407.92% | +514.67% | +421.58% | +411.00% | +441.10% | +426.31% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Asset turnover | 0.74 | 0.85 | 0.68 | 0.72 | 0.72 | 0.72 | 0.72 | 0.69 | 0.70 |
| Fixed-asset turnover | 3.63 | 3.86 | 3.20 | 3.14 | 2.79 | — | — | — | — |
| Inventory turnover | 1.53 | 1.47 | 1.53 | 2.03 | 1.80 | — | — | — | — |
| Receivables turnover | 9.53 | 10.89 | 10.96 | 9.04 | 9.34 | — | — | — | — |
| Payables turnover | 2.27 | 2.36 | 2.73 | 3.07 | 2.49 | — | — | — | — |
| Days outstanding | |||||||||
| Days sales outstanding (DSO) | 38.31 | 33.52 | 33.31 | 40.39 | 39.09 | — | — | — | — |
| Days inventory outstanding (DIO) | 238.48 | 247.57 | 238.24 | 179.45 | 202.95 | — | — | — | — |
| Days payables outstanding (DPO) | 161.08 | 154.48 | 133.56 | 118.81 | 146.49 | — | — | — | — |
| Cash conversion cycle | 115.71 | 126.62 | 138.00 | 101.03 | 95.55 | — | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 1.27 | 1.27 | 1.72 | 6.05 | -1.12 | 38.40 | 38.13 | 40.27 | 39.36 |
| FCF / Net income | 1.04 | 0.84 | -1.55 | 3.69 | -0.59 | 4.58 | 4.61 | 4.52 | 4.65 |
| FCF margin | +18.46% | +11.28% | -9.79% | +9.23% | +4.69% | +1.37% | +1.41% | +1.34% | +1.38% |
| OCF margin | +22.39% | +17.13% | +10.88% | +15.12% | +8.90% | +11.44% | +11.67% | +11.90% | +11.68% |
| CapEx / Revenue | +3.93% | +5.86% | +20.67% | +5.89% | +4.21% | +10.23% | +10.40% | +10.10% | +10.55% |
| CapEx / D&A | 0.98 | 1.45 | 4.49 | 1.11 | 0.73 | — | — | — | — |
| Stock-based comp / Revenue | 0.00% | 0.00% | 0.00% | 0.00% | +2.13% | — | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 7.79 | 6.55 | 2.79 | 1.08 | -3.15 | 2.43 | 3.19 | 3.87 | 4.57 |
| EPS · basic | 7.91 | 6.64 | 2.81 | 1.09 | -3.15 | 2.46 | 3.19 | 3.90 | 4.62 |
| Book value / share | 18.87 | 17.63 | 17.78 | 14.73 | 10.73 | 13.69 | 14.72 | 15.09 | 16.06 |
| Tangible BV / share | 0.64 | 1.32 | -4.63 | -5.58 | -5.63 | 13.69 | 14.72 | 15.09 | 16.06 |
| Sales / share | 44.04 | 48.61 | 44.08 | 43.26 | 39.68 | 41.70 | 43.44 | 45.60 | 47.75 |
| Operating CF / share | 9.86 | 8.33 | 4.80 | 6.54 | 3.53 | 4.77 | 5.07 | 5.42 | 5.58 |
| Free cash flow / share | 8.13 | 5.48 | -4.32 | 3.99 | 1.86 | 0.57 | 0.61 | 0.61 | 0.66 |
| Dividends / share | 2.05 | 2.30 | 2.56 | 2.62 | 1.72 | 2.25 | 2.36 | 2.50 | 2.54 |
| Payout ratio | +26.24% | +35.15% | +91.95% | +242.82% | -54.55% | +1811.40% | +1777.78% | +1858.93% | +1789.55% |
| Retention ratio | +73.76% | +64.85% | +8.05% | -142.82% | +154.55% | -1711.40% | -1677.78% | -1758.93% | -1689.55% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E | 8y CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Top-line | ||||||||||
| Revenue · YoY | — | +9.39% | -10.30% | -1.90% | -8.46% | +4.74% | +4.09% | +4.37% | +4.95% | +0.64% |
| Gross profit · YoY | — | +8.49% | -15.53% | -1.43% | -5.60% | +2.83% | +1.81% | +7.20% | +4.48% | -0.00% |
| Profit | ||||||||||
| Operating income · YoY | — | +21.08% | -52.40% | -35.72% | -1.24% | +18.68% | +2.30% | +5.87% | +0.47% | -8.94% |
| EBITDA · YoY | — | -5.42% | -39.03% | -17.57% | -90.23% | +668.55% | +2.62% | +2.72% | +3.90% | -11.08% |
| Net income · YoY | — | -16.72% | -57.91% | -61.23% | -390.51% | +103.94% | +6.95% | +0.70% | +5.42% | -39.63% |
| Operating | ||||||||||
| EBIT · YoY | — | -8.59% | -48.42% | -30.39% | -155.30% | +201.77% | +6.12% | +6.55% | +3.71% | -17.40% |
| R&D · YoY | — | -100.00% | — | — | — | -65.90% | +8.12% | +0.95% | +3.75% | -8.25% |
| Per-share | ||||||||||
| EPS · diluted · YoY | — | -15.92% | -57.40% | -61.29% | -391.67% | +177.15% | +31.15% | +21.42% | +18.23% | -6.44% |
| EPS · basic · YoY | — | -16.06% | -57.68% | -61.21% | -388.99% | +178.16% | +29.47% | +22.20% | +18.48% | -6.51% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Leverage | |||||||||
| Total debt | $8.1B | $7.65B | $10.17B | $9.83B | $9.44B | $9.45B | $10.05B | $10.41B | $11.01B |
| Net debt | $3.14B | $3.69B | $6.14B | $6.43B | $6.52B | $6.14B | $6.65B | $6.66B | $7.06B |
| Net debt / EBITDA | 0.76 | 0.94 | 2.56 | 3.26 | 33.77 | 4.14 | 4.37 | 4.26 | 4.35 |
| Debt / equity | 1.17 | 1.19 | 1.58 | 1.85 | 2.44 | 1.93 | 1.90 | 1.93 | 1.92 |
| Debt / assets | +36.86% | +36.56% | +43.43% | +45.33% | +47.45% | +45.66% | +46.33% | +43.85% | +45.01% |
| Equity / assets | +31.62% | +30.76% | +27.41% | +24.51% | +19.43% | +23.72% | +24.33% | +22.67% | +23.46% |
| Coverage | |||||||||
| EBITDA / interest expense | 24.02 | 23.53 | 9.40 | 5.22 | 0.48 | 4.41 | 4.27 | 4.12 | 4.15 |
| Operating income / interest | 15.13 | 18.98 | 5.92 | 2.57 | 2.37 | 3.38 | 3.26 | 3.24 | 3.16 |
| Interest expense | $173M | $167M | $255M | $378M | $404M | $336.5M | $356.73M | $379.87M | $391.72M |
| Liquidity | |||||||||
| Current ratio | 1.84 | 1.60 | 1.46 | 1.39 | 1.30 | — | — | — | — |
| Quick ratio | 1.26 | 0.96 | 0.88 | 0.90 | 0.82 | — | — | — | — |
| Cash ratio | 0.94 | 0.68 | 0.65 | 0.60 | 0.54 | — | — | — | — |
| Working capital | $4.47B | $3.48B | $2.9B | $2.22B | $1.63B | — | — | — | — |
| Working capital / revenue | +27.57% | +19.64% | +18.22% | +14.22% | +11.44% | — | — | — | — |
Sourced from key_metrics + financial_ratios (loaded by load_fundamentals_extended.py).
Valuation
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| P / E | — | — |
| P / B | — | — |
| EV / EBITDA | — | — |
| EV / Sales | 2.49x | 2.84x |
| Earnings yield | -3.9% | 1.0% |
| FCF yield | 2.3% | 3.8% |
Returns
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Gross margin | — | — |
| Operating margin | — | — |
| Net margin | — | — |
| ROE | -29.3% | 7.3% |
| ROA | -5.7% | 1.8% |
| ROIC | 6.4% | 3.1% |
Leverage & liquidity
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Debt / equity | — | — |
| Net debt / EBITDA | 33.77 | 3.26 |
| Interest coverage | — | — |
| Current ratio | 1.30x | 1.39x |
| Quick ratio | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).